{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:23:22Z","timestamp":1794939802085,"version":"4.9.1"},"reference-count":39,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Sarcopenia is frequently observed in cancer patients and is associated with short survival. In this study, the aim was to research the sarcopenia risk factors, the correlation of sarcopenia with inflammatory biomarkers, and the prognostic significance of sarcopenia and inflammation markers in patients with metastatic gastric cancer. Material and Method: The study included 177 patients diagnosed with metastatic gastric cancer attending Dokuz Eyl\u00fcl University Faculty of Medicine (DEUFM) Medical Oncology clinic from 2016 to 2022. The skeletal muscle area at L3 vertebral level was identified on abdominal computed tomography (CT) images, and the skeletal muscle index (SMI, cm2\/m2) was calculated. Additionally, PLR, MLR, NLR, dNLR, SIRI, SII, PIV, PNI, CAR, and LAR were assessed among systemic inflammatory biomarkers. Cut-off values were determined with ROC curve analysis. Survival analyses were performed with the Kaplan\u2013Meier method, and risk factors were investigated with Cox regression analysis. For all statistical analyses, p &lt; 0.05 was accepted as significant. Results: Among patients, 71.8% were identified to have sarcopenia. Significant levels of difference were identified for median SIRI, NLR, MLR, PLR, SII, PNI, and dNLR values between patients with and without sarcopenia (p &lt; 0.05). The sarcopenia risk was assessed between groups created according to the cut-off values for inflammation markers. Univariate regression analysis found that SIRI, PIV, NLR, MLR, PLR, SII, PNI, and dNLR were statistically significant (p &lt; 0.05). Multivariate analysis identified SIRI and PNI as independent risk factors. For all patients, median overall survival was identified to be 12.4 \u00b1 0.8 months (CI 95%, 10.8\u201313.9). For patients with sarcopenia, overall survival duration was 11.5 \u00b1 0.8 months, while survival duration for patients without sarcopenia was 17.5 \u00b1 4.6 months (p = 0.010). Elevation in the inflammatory biomarkers of SIRI, NLR, SII, LAR, and CAR and low PNI values appear to be associated with short survival (p &lt; 0.05). Conclusions: In this study, sarcopenia was frequently observed in patients with metastatic gastric cancer and sarcopenia was associated with shorter survival. A significant correlation was observed between sarcopenia and inflammatory biomarkers, with SIRI and PNI identified to be independent risk factors for sarcopenia. Our study emphasizes the prognostic importance of sarcopenia and inflammatory markers for the management of patients with metastatic gastric cancer.<\/jats:p>","DOI":"10.3390\/medicina61050785","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T12:04:33Z","timestamp":1745409873000},"page":"785","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Association of Systemic Inflammatory Response Index and Prognostic Nutritional Index Scores with Sarcopenia in Patients with Metastatic Gastric Cancer"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1600-4185","authenticated-orcid":false,"given":"Busra","family":"Kanbur","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Savastepe State Hospital, Balikesir 10580, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9124-6123","authenticated-orcid":false,"given":"Ilkay Tugba","family":"Unek","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dokuz Eylul University, Izmir 35340, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8596-4233","authenticated-orcid":false,"given":"Mehmet","family":"Uzun","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kahramanmaras Necip Fazil City Hospital, Kahramanmaras 46050, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caner","family":"Ozturk","sequence":"additional","affiliation":[{"name":"Department of Radiology, Dokuz Eyl\u00fcl University, Izmir 35340, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raif Can","family":"Yarol","sequence":"additional","affiliation":[{"name":"Department of Radiology, Dokuz Eyl\u00fcl University, Izmir 35340, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Balci","sequence":"additional","affiliation":[{"name":"Department of Radiology, Dokuz Eyl\u00fcl University, Izmir 35340, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Machlowska, J., Baj, J., Sitarz, M., Maciejewski, R., and Sitarz, R. (2020). Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21114012"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.annonc.2022.03.274","article-title":"Modified Glasgow Prognostic Score (MGPS) Is Correlated with Sarcopenia and Dominates the Prognostic Role of Baseline Body Composition Parameters in Advanced Gastric and Esophagogastric Junction Cancer Patients Undergoing First-Line Treatment from the Phase III EXPAND Trial","volume":"33","author":"Hacker","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","article-title":"Updates on Global Epidemiology, Risk and Prognostic Factors of Gastric Cancer","volume":"29","author":"Yang","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_5","first-page":"412","article-title":"European Working Group on Sarcopenia in Older People. Sarcopenia: European Consensus on Definition and Diagnosis: Report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Baeyens","year":"2010","journal-title":"Age Ageing"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/lary.28616","article-title":"Radiologically Defined Sarcopenia Affects Survival in Head and Neck Cancer: A Meta-Analysis","volume":"131","author":"Wong","year":"2021","journal-title":"Laryngoscope"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A Practical and Precise Approach to Quantification of Body Composition in Cancer Patients Using Computed Tomography Images Acquired during Routine Care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and Clinical Implications of Sarcopenic Obesity in Patients with Solid Tumours of the Respiratory and Gastrointestinal Tracts: A Population-Based Study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","article-title":"Body Composition as an Independent Determinant of 5-Fluorouracil\u2013Based Chemotherapy Toxicity","volume":"13","author":"Prado","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejso.2014.11.040","article-title":"Sarcopenia Is Associated with Toxicity in Patients Undergoing Neo-Adjuvant Chemotherapy for Oesophago-Gastric Cancer","volume":"41","author":"Tan","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, Inflammation, and Cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1007\/s12029-023-00937-0","article-title":"Diagnostic Utility of NLR, PLR and MLR in Early Diagnosis of Gastric Cancer: An Analytical Cross-Sectional Study","volume":"54","author":"Karra","year":"2023","journal-title":"J. Gastrointest. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pan, Y., Si, H., Deng, G., Chen, S., Zhang, N., Zhou, Q., Wang, Z., and Dai, G. (2022). A Composite Biomarker of Derived Neutrophil\u2013Lymphocyte Ratio and Platelet\u2013Lymphocyte Ratio Correlates with Outcomes in Advanced Gastric Cancer Patients Treated with Anti-PD-1 Antibodies. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.798415"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Yang, X.-C., Liu, H., Liu, D.-C., Tong, C., Liang, X.-W., and Chen, R.-H. (2022). Prognostic Value of Pan-Immune-Inflammation Value in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1036890"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.21037\/jgo.2019.05.03","article-title":"The Prognostic Value of Systemic Immune-Inflammation Index (SII) in Patients after Radical Operation for Carcinoma of Stomach in Gastric Cancer","volume":"10","author":"Wang","year":"2019","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ding, P., Guo, H., Sun, C., Yang, P., Kim, N.H., Tian, Y., Liu, Y., Liu, P., Li, Y., and Zhao, Q. (2022). Combined Systemic Immune-Inflammatory Index (SII) and Prognostic Nutritional Index (PNI) Predicts Chemotherapy Response and Prognosis in Locally Advanced Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy with PD-1 Antibody Sintilimab and XELOX: A Prospective Study. BMC Gastroenterol., 22.","DOI":"10.1186\/s12876-022-02199-9"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hashimoto, I., Kano, K., Onuma, S., Suematsu, H., Nagasawa, S., Kanematsu, K., Furusawa, K., Hamaguchi, T., Watanabe, M., and Hayashi, K. (2023). Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine\/Tipiracil. J. Pers. Med., 13.","DOI":"10.3390\/jpm13060923"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.21873\/anticanres.15188","article-title":"An Elevated Serum Lactate Dehydrogenase-to-Albumin Ratio Is a Useful Poor Prognostic Predictor of Nivolumab in Patients with Gastric Cancer","volume":"41","author":"Nakazawa","year":"2021","journal-title":"Anticancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/jcsm.12800","article-title":"Geriatric Nutrition Risk Index: Prognostic Factor Related to Inflammation in Elderly Patients with Cancer Cachexia","volume":"12","author":"Ruan","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","article-title":"Prognostic Value of Sarcopenia in Adults with Solid Tumours: A Meta-Analysis and Systematic Review","volume":"57","author":"Shachar","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.critrevonc.2018.09.016","article-title":"The Prognostic Value of the Systemic Inflammatory Response in Randomised Clinical Trials in Cancer: A Systematic Review","volume":"132","author":"Dolan","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10120-018-0882-2","article-title":"Body Composition Assessment and Sarcopenia in Patients with Gastric Cancer: A Systematic Review and Meta-Analysis","volume":"22","author":"Kamarajah","year":"2019","journal-title":"Gastric Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lee, J.S., Kim, Y.S., Kim, E.Y., and Jin, W. (2018). Prognostic Significance of CT-Determined Sarcopenia in Patients with Advanced Gastric Cancer. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0202700"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e204783","DOI":"10.1001\/jamanetworkopen.2020.4783","article-title":"Assessment of Sarcopenia Measures, Survival, and Disability in Older Adults Before and After Diagnosis with Cancer","volume":"3","author":"Williams","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13539-012-0065-7","article-title":"Hypogonadism in Male Cancer Patients","volume":"3","author":"Burney","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ggi.12220","article-title":"Incidence, Reversibility, Risk Factors and the Protective Effect of High Body Mass Index against Sarcopenia in Community-Dwelling Older Chinese Adults","volume":"14","author":"Yu","year":"2014","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zhao, M., Duan, X., Han, X., Wang, J., Han, G., Mi, L., Shi, J., Li, N., Yin, X., and Hou, J. (2022). Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated with Immune Cells. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.854096"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.2147\/CMAR.S175421","article-title":"Sarcopenia Is Associated with the Neutrophil\/Lymphocyte and Platelet\/Lymphocyte Ratios in Operable Gastric Cancer Patients: A Prospective Study","volume":"10","author":"Lin","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e1091","DOI":"10.1634\/theoncologist.2018-0651","article-title":"Prognostic Value and Association of Sarcopenia and Systemic Inflammation for Patients with Gastric Cancer Following Radical Gastrectomy","volume":"24","author":"Lin","year":"2019","journal-title":"Oncologist"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ding, P., Lv, J., Sun, C., Chen, S., Yang, P., Tian, Y., Zhou, Q., Guo, H., Liu, Y., and Zhao, Q. (2022). Combined Systemic Inflammatory Immunity Index and Prognostic Nutritional Index Scores as a Screening Marker for Sarcopenia in Patients with Locally Advanced Gastric Cancer. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.981533"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1245\/s10434-018-6624-1","article-title":"Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial","volume":"25","author":"Park","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clnu.2023.11.009","article-title":"Sarcopenia Affects the Clinical Efficacy of Immune Checkpoint Inhibitors in Patients with Gastrointestinal Cancers","volume":"43","author":"Lilong","year":"2024","journal-title":"Clin. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Liu, Z., Ge, H., Miao, Z., Shao, S., Shi, H., and Dong, C. (2021). Dynamic Changes in the Systemic Inflammation Response Index Predict the Outcome of Resectable Gastric Cancer Patients. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.577043"},{"key":"ref_34","first-page":"e23972","article-title":"Effect of C-Reactive Protein-to-Albumin Ratio on Prognosis in Gastric Cancer Patients","volume":"14","author":"Alkurt","year":"2022","journal-title":"Cureus"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","article-title":"International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management","volume":"22","author":"Dent","year":"2018","journal-title":"J. Nutr. Health Aging"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e068788","DOI":"10.1136\/bmj-2021-068788","article-title":"Multicomponent Intervention to Prevent Mobility Disability in Frail Older Adults: Randomised Controlled Trial (SPRINTT Project)","volume":"377","author":"Bernabei","year":"2022","journal-title":"BMJ"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"De Felice, F., Malerba, S., Nardone, V., Salvestrini, V., Calomino, N., Testini, M., Boccardi, V., Desideri, I., Gentili, C., and De Luca, R. (2025). Progress and Challenges in Integrating Nutritional Care into Oncology Practice: Results from a National Survey on Behalf of the NutriOnc Research Group. Nutrients, 17.","DOI":"10.3390\/nu17010188"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Bossi, P., Delrio, P., Mascheroni, A., and Zanetti, M. (2021). The Spectrum of Malnutrition\/Cachexia\/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review. Nutrients, 13.","DOI":"10.3390\/nu13061980"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2217\/bmm-2022-0748","article-title":"Evaluation of Sarcopenia as a Prognostic Biomarker in Locally Advanced Head and Neck Squamous Cell Carcinoma","volume":"17","author":"Erul","year":"2023","journal-title":"Biomark. Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/5\/785\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:20:25Z","timestamp":1760030425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/5\/785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["medicina61050785"],"URL":"https:\/\/doi.org\/10.3390\/medicina61050785","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]}}}